Research and Markets: Human Insulin Market Development and Demand Forecast to 2020 - Provides Information on the Historical and Current Market Size and the Future Potential of the Market

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/58dptr/global_industry) has announced the addition of the "Global Industry Insight: Human Insulin Market Development and Demand Forecast to 2020" report to their offering.

Increasing usage of insulin pens for the administration of insulin helps to inject insulin accurately. In addition, growing demand of biosimilar drugs due to its cost effectiveness is an opportunity for the growth of the market.

Human insulin market is growing moderately due to increase in prevalence of diabetic population, rise in geriatric population, rising awareness of diabetes and rising prevalence of obesity. However, strict regulatory requirements for approval of insulin and high cost of analog are inhibiting the growth of the global human insulin market.

Globally, modern human insulin has the largest market share and is also the fastest growing human insulin type. In addition, long acting human insulin has the largest market share in the modern human insulin market, and premixed human insulin is the fastest growing modern human insulin in the market. Long acting human insulin is prescribed by physicians for the treatment of type 2 diabetes.

Report Coverage

  • Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis
  • Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
  • Uncovers potential demands in the market

Key Topics Covered:

1 Research Scope and Methodology

2 Executive Summary

3 Market Outlook

4 Global Market Size and Forecasts (2011 - 2020)

5 Global Market Breakdown by Type

6 Global Traditional Human Insulin Market Breakdown by Type

7 Global Modern Human Insulin Market Breakdown by Type

8 Global Market Breakdown by Brand

9 Global Market Breakdown by Region

10 Competitive Analysis and Market Share

11 Company Profiles

12 Appendix

Companies Mentioned

  • ADOCIA
  • Biocon Ltd.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • Julphar
  • Merck & Co.
  • Novo Nordisk A/S
  • Oramed Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • Sanofi
  • TonghuaDongbao Pharmaceuticals Co., Ltd

For more information visit http://www.researchandmarkets.com/research/58dptr/global_industry

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals